This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit         Apr 15, 2016


 


AAPS CAREER NEWS


Postdoc, What Have You Done for Me Lately?
I often get asked, “Do you think I should do a postdoc?” My answer is the same today as it was 15 years ago, “YES!” Don’t think that a two-year postdoc will only delay your career development by two years. In fact, it’s not unusual for someone with additional postdoctoral experience to come in at a higher starting salary, especially someone with a really successful postdoc.

Read more about how a postdoc can boost your career in Russ Weiner’s April Career Success feature.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


RECENT JOB POSTINGS

Job Title Company Location
Post Doctoral Scientist-Immunology Eli Lilly and Company Indianapolis, Indiana
Sr./Principal Scientist, Process Chemistry Seattle Genetics Bothell, Washington
Systems Pharmacology/Pharmacogenomics Faculty Position Long Island University Brooklyn, New York

For a complete list of job postings, click here.

Have a job to post? Click here.


PHARMACEUTICAL CAREER NEWS


How the Sharing Economy Can Help Scientific Research
Slate
Today’s scientists encounter similar challenges in their research programs. The cost and complexity of science and technology equipment have grown faster than science funding, and research has become so specialized that a gap has grown between the experiments scientists would like to do and the ones they can do. In a market where the latest version of “Next Generation Sequencing” equipment approaches $1 million and is replaced as often as the iPhone, scientists struggle to afford the equipment and to maintain the scientific expertise for emerging technologies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How 3-D Printing Will Change the Pharmaceutical World Forever
The Next Web
New possibilities in 3-D printing may open up a whole new chapter of opportunities for pharmaceutical research and bio-technology applications. There are a number of ways it could be used — drug dosage forms, supporting delivery, or helping to research cures. Let’s explore how that might work.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Career Success — Is It All About the Money?
The Huffington Post
How should we measure career success? Happiness? Wealth? Work/life balance? Being able to contribute to society? Loving what you do for a living? A recent report by the Georgetown University Center on Education and the Workforce says career success is based primarily on earning potential. The research showed that while the more secure, non-manual-labor jobs are going to those with bachelor’s degrees, the best — and most lucrative — careers most often go to college graduates who major in fields that include engineering and pharmaceutical sciences, rather than concentrations that encourage public service, such as social work and education.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Senate Committee Passes Med Tech Regulatory Reforms, Expands Expedited Review Pathway
FierceMedicalDevices
Senators pulled an all-nighter over the weekend and made unexpected progress on medical device regulatory reform that "will help ensure more timely patient access to the latest medical innovations and improve the efficiency of FDA's device review process," according to AdvaMed. The three regulatory bills are expected to be paired with Democratic priorities related to funding the NIH and FDA in a comprehensive package akin to the 21st Century Cures Act, which passed in the House.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA Enhances Label Warnings for Immediate-Release Opioids
PharmTech
On March 22, 2016, FDA announced that it is requiring class-wide safety labeling changes for immediate-release (IR) opioids. The requirement is a part of the agency’s effort to educate prescribers and patients about the potential risks associated with the use of opioid drugs. The changes include a new boxed warning about the risks of misuse, abuse, addiction, overdose, and death. FDA is requiring the warning to include a precaution that chronic use of IR opioid analgesics during pregnancy can result in neonatal opioid withdrawal syndrome.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Remote Monitoring and Pharmaceutical Manufacturing
Pharmaceutical Processing
Remote monitoring and diagnostic capabilities are becoming increasingly critical tools in pharmaceutical processing and packaging operations, and for good reason. With the ability to monitor plant operations 24/7, manufacturers can detect and correct problems sooner, reduce downtime, and make smarter decisions. These tools can help improve overall equipment efficiency (OEE) not only within one line or one plant, but within an entire global network of operations.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


How To Write Your Medical Sales Resume Like a Newspaper Article And Pass the 6-Second Scan Test
MedReps
The term “resume reading” should be obsolete in today’s job market. Given that the average reader spends between 6 and 20 seconds on the first pass, we should really refer to it as “resume scanning.” The idea of a medical or pharmaceutical sales recruiter scanning versus reading your resume may be irritating — after all, you’ve spent hours, days, or maybe even weeks working on it! Skim readers are a reality though, so it’s essential that you understand the paths our eyes take and make sure these areas include powerful verbiage.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Twitter, Facebook, Google Execs Examine Regulatory Limits For Drugmakers
Medical Marketing & Media
Executives at Twitter, Google, and Facebook say ongoing uncertainty about FDA regulations limits how well drugmakers can engage with patients on social media platforms. At the annual ePharma conference in New York City, executives from the technology giants participated in a panel focused on discussing how the pharma industry can keep up with the rapid development of digital technology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Johnson & Johnson's Phase 3 Cancellation: Why It Matters
Seeking Alpha
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that it is discontinuing the Phase 3 development program for fulranumab in osteoarthritis pain. This decision was based on strategic portfolio prioritization and was not based on any emerging safety concerns from the Phase 3 clinical studies with fulranumab. Janssen Pharmaceuticals, Inc., an affiliated company, is terminating its licensing agreement with Amgen Inc. for fulranumab and is returning all program rights back to Amgen.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The First Amendment And Pharmaceutical Promotion
Health Affairs Blog
Large teams of FDA scientists with expertise in pharmacology, clinical trials, epidemiology, statistics, and several other disciplines take six to 10 months to review the massive dossiers submitted by manufacturers to win drug approval. The idea that unfettered “commercial free speech” would make it possible for prescribers to come up with equally useful determinations on their own is simply implausible.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Digital Marketing Strategies Changing Pharma Sales Models
MediaPost
As patients continue to grow more comfortable in a digital world and more savvy about their health care options, pharmaceutical manufacturers are changing their sales models, according to a recent study. Best Practices, LLC, surveyed 39 digital marketers at 30 large and small pharmaceutical companies to examine the most effective marketing strategies, identify innovative approaches and look for trends.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit

Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

March 11, 2016
Feb. 12, 2016
Jan. 8, 2016
Dec. 11, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063